IP Library Granted Patent US 7,399,627
Granted Patent B2
US 7,399,627 · App. 10/394,568 · Granted Jul 15, 2008

Transformation system in the field of filamentous fungal hosts

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,399,627
App. No.
10/394,568
Granted
Jul 15, 2008
Kind
B2
Abstract

A novel transformation system in the field of filamentous fungal hosts for expressing and secreting heterologous proteins or polypeptides is described. The invention also covers a process for producing large amounts of polypeptide or protein in an economical manner. The system comprises a transformed or transfected fungal strain of the genus Chrysosporium , more particularly of Chrysosporium lucknowense and mutants or derivatives thereof. It also covers transformants containing Chrysosporium coding sequences, as well expression-regulating sequences of Chrysosporium genes. Also provided are novel fungal enzymes and their encoding sequences and expression-regulating sequences.

Claims (6)

1. A mutant Chrysosporium strain comprising a nucleic acid sequence encoding a polypeptide of interest, said nucleic acid sequence being operably linked to a promoter sequence and optionally a secretion signal sequence, said mutant strain expressing said polypeptide of interest at a higher level than the corresponding non-mutant strain under the same conditions, wherein said mutant derived from Chrysosporium lucknowense is UV13-6 (VKM F-3632 D), NG7C-19 (VKM F-3633 D), or UV18-25 (VKM F-3631 D) or is derived from a Chrysosporium lucknowense strain of C. lucknowense strain C1 (VKM F-3500 D), UV13-6 (VKM F-3632 D), NG7C-19 (VKM F-3633 D), or UV18-25 (VKM F-3631 D).

2. A mutant Chrysosporium strain wherein said mutant is or is derived from a Chrysosporium lucknowense mutant strain selected from the group consisting of UV13-6 (VKM F-3632 D), NG7C-19 (VKM F-3633 D), and UV18-25 (VKM F-3631 D).

3. The mutant Chrysosporium strain of claim 2 wherein said mutant is or is derived from a Chrysosporium lucknowense mutant strain UV13-6 (VKM F-3632 D).

4. The mutant Chrysosporium strain of claim 2 wherein said mutant is or is derived from a Chrysosporium lucknowense mutant strain NG7C-19 (VKM F-3633 D).

5. The mutant Chrysosporium strain of claim 2 wherein said mutant is or is derived from a Chrysosporium lucknowense mutant strain UV18-25 (VKM F-3631 D).

6. The mutant Chrysosporium strain of claim 2 , 3 , 4 or 5 wherein said mutant strain expresses a polypeptide of interest at a higher level than the corresponding original mutant strain under the same conditions.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2016
From: DYADIC INTERNATIONAL (USA), INC.
To: DANISCO US INC.
Reel/Frame 038240/0532 →
SECURITY AGREEMENT:UCC FINANCING STATEMENT Recorded Nov 14, 2008
From: DYADIC INTERNATIONAL (USA), INC.; DYADIC INTERNATIONAL, INC.
To: MARK A. EMALFARB TRUST; FRANCISCO TRUST; EMALFARB, MARK A.
Reel/Frame 021838/0239 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2008
From: EMALFARB, MARK AARON; BURLINGAME, RICHARD PAUL; OLSON, PHILIP TERRY; SINITSYN, ARKADY PANTELEIMONOVICH; PARRICHE, MARTINE; BOUSSON, JEAN CHRISTOPHE; PYNNONEN, CHRISTINE MARIE; PUNT, PETER JAN; VAN ZEIJL, CORNELIA MARIA JOHANNA
To: DYADIC INTERNATIONAL, INC.
Reel/Frame 021773/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2008
From: DYADIC INTERNATIONAL, INC.
To: DYADIC INTERNATIONAL (USA), INC.
Reel/Frame 020741/0854 →